| Literature DB >> 27809762 |
Louise F Thatcher1, Angela H Williams2,3, Gagan Garg2, Sally-Anne G Buck2, Karam B Singh2,3.
Abstract
BACKGROUND: Pathogenic members of the Fusarium oxysporum species complex are responsible for vascular wilt disease on many important crops including legumes, where they can be one of the most destructive disease causing necrotrophic fungi. We previously developed a model legume-infecting pathosystem based on the reference legume Medicago truncatula and a pathogenic F. oxysporum forma specialis (f. sp.) medicaginis (Fom). To dissect the molecular pathogenicity arsenal used by this root-infecting pathogen, we sequenced its transcriptome during infection of a susceptible and resistant host accession.Entities:
Keywords: DEG; Effector; Fusarium wilt; Hemibiotroph; Necrotroph; RNA-Seq; Secreted In Xylem; Small secreted protein; Vascular wilt; root pathogen
Mesh:
Year: 2016 PMID: 27809762 PMCID: PMC5094085 DOI: 10.1186/s12864-016-3192-2
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Disease symptoms and Fom colonisation of resistant and susceptible M. truncatula accessions. a-d Disease symptoms of Fom inoculated A17 and DZA315 M. truncatula seedlings. a Percentage of diseased seedlings at 7, 14 and 21 days post inoculation (dpi) with b) an image of representative seedlings at 14 dpi. White arrows highlight disease symptoms of wilting, chlorotic and necrotic leaves. c Average survival and d above ground fresh weight of mock (control) or Fom inoculated seedlings at 21 dpi. For a, c and d values are averages ± SE (n = 10). Similar results were obtained in independent experiments. e Relative Fom fungal abundance determined by qRT-PCR analysis of Fom_18S relative to M. truncatula_18S in samples harvested at 1, 2, 4 and 7 dpi. Samples are averages ± SE of 4 biological replicates consisting of pools of 10 seedlings. Asterisks indicate values that are significantly different (**P < 0.01 Student’s t-test) between A17 and DZA315 at the respective time point
Mapping results of RNA-Seq data from Fusarium infected A17 (resistant) or DZA315 (susceptible) root samples
| in vitro | Inf. A17 2 dpi | Inf. A17 7 dpi | Inf. DZA315 2 dpi | Inf. DZA315 7 dpi | |
|---|---|---|---|---|---|
| Pre-processed reads for each replicate (million pairs) | 58.7 ± 1.5 | 56.2 ± 1.4 | 55.5 ± 1.6 | 53.4 ± 0.9 | 55.4 ± 0.6 |
| Range of read pair numbers mapped | 54,789,566 ± 1,026,861.7 | 12,626.0 ± 951.5 | 30,343.2 ± 6,309.8 | 14,713.8 ± 1,745.2 | 91,061.5 ± 5,934.4 |
| % range of reads mapped | 92.6-94.2 | 0.016-0.028 | 0.021-0.080 | 0.021-0.038 | 0.139-0.194 |
| Pairs with multiple alignments (%) | 0.2 | 0.4-0.5 | 0.4-0.5 | 0.2-0.3 | 0.4-0.5 |
Inf Fom infected, dpi days post inoculation; ±: SE
Fig. 2Number of Fom genes differentially expressed between in vitro and in planta samples. a DEGs detected between Fom grown in vitro (IV) and during infection of A17 or DZA315 roots at 2 or 7 days post inoculation (dpi). b-c Venn diagrams of DEGs in overlapping datasets from b) A17 and c) DZA315. Red and black arrows indicate up- or down-regulated in planta respectively
Differentially expressed Fusarium genes detected during infection of A17 or DZA315 roots
| Proportion of gene model coverage | A17 2 dpi vs IV | A17 7 dpi vs IV | DZA315 2 dpi vs IV | DZA315 7 dpi vs IV | ||||
|---|---|---|---|---|---|---|---|---|
| up | down | up | down | up | down | up | down | |
| ≥25 % | 107 | 90 | 128 | 88 | 117 | 108 | 446 | 333 |
| ≥50 % | 64 | 21 | 63 | 34 | 66 | 35 | 281 | 141 |
| ≥95 % | 13 | 1 | 25 | 5 | 17 | 4 | 105 | 28 |
IV in vitro. Note, DEGs in ≥ 95 % are also captured within the ≥ 50 % and ≥ 25 % datasets. Likewise, DEGs in ≥ 50 % are captured within the ≥ 25 % dataset
Fig. 3Pfam domains more abundant in the in planta up-regulated datasets. Pfam domains enriched in the in planta up-regulated datasets from resistant (A17) and susceptible (DZA315) accessions relative to in vitro growth conditions are listed. Schematic figures illustrate the tissue sampled (represented as root tissues below the dashed line infected with Fom (purple spores), highlighting the chlorotic leaves visible at the later stage of the susceptible interaction). Enriched Pfam domains were identified based on comparisons against the total Fom protein set using Fisher’s exact test with a significance threshold of p ≤ 0.05. Values are ranked by representation of Pfam domains with colour coding signifying increasing abundance within each dataset. Cs: counts of Pfam domain containing proteins in DEG dataset. % D: % representation of Pfam domain containing proteins in DEG dataset; % G: % representation of Pfam domain containing proteins in whole genome. Further details are provided in Additional File 6. Aldeh: Aldehyde dehydrogenase; AIM24: Mitochondrial biogenesis; CIA30: mitochondrial Complex I intermediate-associated protein; Dabb: Stress responsive A/B Barrel Domain; EutQ: Ethanolamine utilisation protein; GH: glycoside hydrolase; Grp1_Fun34_YaaH: acetate transporter; GFA: Glutathione-dependent formaldehyde-activating enzyme; GST: Glutathione S-transferase; HAD: Haloacid dehalogenase-like hydrolase; LigB: LigB subunit of aromatic ring-opening dioxygenase; Meth_synthase: methionine synthases; NDT80_PhoG: DNA binding-family; PLAC8: Placenta-specific gene 8 protein; Pyr_redox: Pyridine nucleotide-disulphide oxidoreductase (includes oxidoreductases, NADH oxidases and peroxidases); SBP: Bacterial extracellular solute-binding protein; Thiamine4: thiamine biosynthetic enzyme
Fig. 4DEGs in up-regulated datasets contain an enrichment of genes located on putative non-core chromosomes and encoding predicted small secreted proteins. a-b Predicted putative chromosomal location of DEGs with a) total numbers in each dataset and b) percentage of DEGs predicted to reside on a predicted conditionally dispensable chromosome (CDC). c DEGs predicted to encode small secreted proteins within each dataset
Fig. 5Unique and overlapping Fom DEGs between A17 and DZA315 in planta up-regulated datasets. Venn diagram of DEGs in overlapping A17 and DZA315 in planta up-regulated datasets. Red arrows indicate up-regulated in planta
Examples of genomic co-localisation of in planta up-regulated differentially expressed Fom genes unique to DZA315 or A17 datasets. Full DEG lists are detailed in Additional files 2 and 3
| Dataset | Gene IDs | Chrom./ scaffolda | Pfam domain / best BlastP match / other characteristics |
|---|---|---|---|
| A17 2 dpi |
| core (scaffold_15; 1.38 Mb) | GST, MFS transporter, FAD-binding, uncharacterised protein |
| DZA315 7 dpi |
| core (scaffold_2; 3.35 Mb) | glycoside hydrolase, fasciclin, MFS transporter |
|
| core (scaffold_2; 3.35 Mb) | arca-like protein, MFS transporter, glycoside hydrolase | |
|
| core (scaffold_4; 2.62 Mb) | Hypothetical, MFS transporter, synthase | |
|
| core (scaffold_131; 0.03 Mb) | FAD-binding protein, ADH, FAD-binding protein, p450 | |
|
| CDC (scaffold_31; 0.21 Mb) | Oxidoreductase, MFS transporter, FAD-binding protein, oxidase |
apredicted core or CD chromosome (CDC) location and scaffold size based on [5]
Differentially expressed Fom genes significantly up-regulated in planta during infection of DZA315 or A17 at 2 and 7 dpi. DEGs are ranked by DZA315 fold change (FC) over in vitro at 2 dpi. Bold FC indicates DZA315 fold changes greater than A17
| Protein ID | Chrom./scaffolda | Sec. pred.b | SSPc | Eff.P pred.d | AAe | Potential rolef | DZA315 FCg | A17 FCg | IV h | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2dpi | 7dpi | 2dpi | 7dpi | ||||||||
| Fom_SIX13 | CDC | + | SSP | - |
| SIX effector |
|
| 280959 | 1123836 | - |
| Fom_16257 | CDC | + | SSP | + |
| uncharacterised |
|
| 150562 | 301124 | - |
| Fom_16301 | CDC | + | SSP | + |
| LysM |
|
| 114105 | 425854 | - |
| Fom_16235 | CDC | + | SSP | + |
| uncharacterised |
|
| 35120 | 131072 | + |
| Fom_15517 | CDC | - | 567 | abhydrolase/peptidase |
| 7132 | 7643 | 8780 | + | ||
| Fom_16729 | core | - |
| Protease (partial) | 11585 |
| 23170 | 114105 | - | ||
| Fom_16326 | CDC | + | SSP | + |
| uncharacterised |
|
| 7132 | 57052 | + |
| Fom_SIX1 | CDC | + | SSP | - |
| SIX effector |
|
| 10809 | 40342 | + |
| Fom_SIX8 | CDC | + | SSP | + |
| SIX effector |
|
| 8192 | 70240 | + |
| Fom_16154 | CDC | + | - | 610 | GMC_oxidoreductase |
|
| 3566 | 12417 | + | |
| Fom_16208 | core | - |
| peptidase |
|
| 2048 | 15287 | + | ||
| Fom_12303 | core | + | SSP | + |
| uncharacterised | 2195 |
| 2353 | 23170 | - |
| Fom_16263 | CDC | - |
| uncharacterised |
|
| 1911 | 6208 | + | ||
| Fom_15948 | CDC | + | SSP | + |
| peroxidase |
|
| 1097 | 6654 | + |
| Fom_10610 | core | + | - | 478 | oxidoreductase |
|
| 1448 | 2896 | + | |
| Fom_16592 | CDC | - |
| uncharacterised |
|
| 630 | 3566 | + | ||
| Fom_15730 | CDC | - |
| GST |
|
| 315 | 588 | + | ||
| Fom_15949 | CDC | - | 373 | peroxidase | 776 |
| 776 | 4096 | + | ||
| Fom_09820 | core | - | 545 | p450 |
| 239 | 388 | 239 | + | ||
| Fom_09550 | core | - |
| uncharacterised | 446 | 3566 | 1097 | 3822 | + | ||
| Fom_SIX9 | CDC | + | SSP | + |
| SIX effector |
|
| 208 | 1024 | + |
| Fom_15614 | CDC | + | SSP | - |
| glyco_hydrolase |
|
| 181 | 274 | + |
| Fom_06101 | core | - | 420 | uncharacterised |
|
| 181 | 128 | + | ||
| Fom_14503 | core | - |
| SnoaL | 169 |
| 223 | 45 | + | ||
| Fom_07856 | core | - | 533 | MFS |
|
| 97 | 84 | + | ||
| Fom_16718 | core | - |
| protease | 111 |
| 208 | 1176 | + | ||
| Fom_07866 | core | - |
| uncharacterised |
|
| 60 | 34 | + | ||
| Fom_16085 | CDC | - | 403 | 2OG-FeII_Oxy |
|
| 52 | 315 | + | ||
| Fom_10284 | core | - |
| ligase |
| 239 | 49 | 338 | + | ||
| Fom_02574 | core | + | SSP | + |
| uncharacterised |
|
| 32 | 24 | + |
| Fom_04867 | core | - |
| NAD_binding |
|
| 32 | 9 | + | ||
| Fom_07859 | core | - |
| LigB, dioxyenase |
|
| 11 | 11 | + | ||
| Fom_01704 | core | - | 398 | methionine synth. | 24 |
| 32 | 23 | + | ||
| Fom_13701 | core | - | 391 | oxidoreductase |
|
| 20 | 11 | + | ||
| Fom_12076 | core | + | - | 324 | uncharacterised | 21 |
| 26 | 20 | + | |
| Fom_02353 | core | + | SSP | - |
| endoglucanase | 21 |
| 23 | 23 | + |
| Fom_15788 | CDC | + | SSP | + |
| uncharacterised |
|
| 11 | 49 | + |
| Fom_04087 | core | + | SSP | + |
| uncharacterised |
|
| 13 | 42 | + |
| Fom_10931 | core | + | - | 330 | pectinesterase | 11 |
| 20 | 26 | + | |
| Fom_08395 | core | + | SSP | - |
| abhydrolase |
|
| 6 | 5 | + |
| Fom_16385 | CDC | - |
| glyco_hydrolase | 9 |
| 10 | 30 | + | ||
| Fom_07662 | core | - | 438 | aminotransferase |
|
| 4 | 16 | + | ||
| Fom_08559 | core | + | - | 433 | glyco_hydrolase | 8 |
| 9 | 37 | + | |
| Fom_04883 | core | - | 514 | p450 | 7 |
| 7 | 5 | + | ||
| Fom_15521 | CDC | - | 660 | AMP-binding |
| 5 | 5 | 5 | + | ||
| Fom_05481 | core | + | SSP | - | 292 | uncharacterised |
|
| 5 | 3 | + |
| Fom_01040 | core | - | 124 | uncharacterised | 6 | 7 | 12 | 8 | + | ||
| Fom_16221 | CDC | - | 83 | glyco_hydrolase | 5 |
| 6 | 23 | + | ||
| Fom_16350 | core | - | 174 | abhydrolase | 5 | 2 | 5 | 4 | + | ||
| Fom_10260 | core | - | 255 | flavodoxin |
|
| 3 | 5 | + | ||
| Fom_09704 | core | + | - | 418 | glyco_hydrolase | 4 |
| 4 | 17 | + | |
apredicted core or CD chromosome (CDC) location
bpredicted secreted based on SignalP
cpredicted small secreted protein (SSP) based on ≤ 300 amino acids, SignalP, and ≤1 transmembrane domains
dEffectorP prediction (performed if predicted to be secreted): + effector, - non-effector
eBold font: protein length ≤ 300 amino acids
fPotential role based on Pfam domain, best BlastP match or other characteristics
gFold change in planta gene expression over in vitro conditions
hexpression in vitro, –: 0-10 % RNA-Seq read coverage over all replicates, +: >10 % RNA-Seq read coverage over all replicates
Fig. 6qRT-PCR validation of candidate effector genes in vitro versus in planta over an infection time-course. Expression of candidate effector genes as determined by qRT-PCR in in vitro samples and M. truncatula DZA315 and A17 root samples harvested at 1, 2, 4 and 7 days post inoculation (dpi) with Fom. in vitro samples are averages ± SE of 3 biological replicates. In planta samples are averages ± SE of 4 biological replicates each consisting of pools of 10 seedlings. Gene expression levels are relative to the fungal GPDA gene (Fom_05751). Note: * No detectable expression in any in vitro replicates